Capricor Therapeutics Inc (NASDAQ:CAPR) price on Thursday, March 20, rose 17.51% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $14.36.
A look at the stock’s price movement, the close in the last trading session was $12.22, moving within a range at $12.234 and $14.75. Turning to its 52-week performance, $23.40 and $3.52 were the 52-week high and 52-week low respectively. Overall, CAPR moved -4.84% over the past month.
Capricor Therapeutics Inc’s market cap currently stands at around $652.95 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-18.
The average forecast suggests down to a -22.76% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 54.4M, representing a 144.26% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CAPR is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CAPR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CAPR’s current price about 5.99% and 2.33% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.15, while 7-day volatility ratio is 10.77% and 10.75% in the 30-day chart. Further, Capricor Therapeutics Inc (CAPR) has a beta value of 4.60, and an average true range (ATR) of 1.30. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $10 and high of $21.5. Looking at the price targets, the low is 30.36% off current price level while to achieve the yearly target high, price needs to move -49.72%. Nonetheless, investors will most likely welcome a -4.46% jump to $15 which is the analysts’ median price.
If we refocus on Capricor Therapeutics Inc (NASDAQ:CAPR), historical trading data shows that trading volumes averaged 1.36 over the past 10 days and 1.15 million over the past 3 months. The company’s latest data on shares outstanding shows there are 40.33 million shares.
The 12.16% of Capricor Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 39.05% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.17 million on 2025-02-28, giving us a short ratio of 8.02. The data shows that as of 2025-02-28 short interest in Capricor Therapeutics Inc (CAPR) stood at 2036.9999999999998 of shares outstanding, with shares short rising to 7.67 million registered in 2025-01-31. Current price change has pushed the stock 4.06% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CAPR stock continues to rise going into the next quarter.
